| GA21264-100g |
|
64709-57-5 |
|
0 |
C13H13ClN2O3 |
|
|
|
| GA21264-25g |
|
64709-57-5 |
|
0 |
C13H13ClN2O3 |
|
|
|
| GA21263-250g |
|
6319-96-6 |
|
0 |
C4H6ClNO3 |
|
|
|
| GA21263-100g |
|
6319-96-6 |
|
0 |
C4H6ClNO3 |
|
|
|
| GA21263-25g |
|
6319-96-6 |
|
0 |
C4H6ClNO3 |
|
|
|
| GA21262-25mg |
|
92899-39-3 |
Chemotactic Domain of Elastin
|
0 |
C22H38N6O7 |
|
|
|
| GA21262-5mg |
|
92899-39-3 |
Chemotactic Domain of Elastin
|
0 |
C22H38N6O7 |
|
|
|
| GA21261-1mg |
|
— |
Checkpoint Protein Hus1 (213-232) (human)
|
0 |
C95H150N30O35S |
|
|
|
| GA21261-005mg |
|
— |
Checkpoint Protein Hus1 (213-232) (human)
|
0 |
C95H150N30O35S |
|
|
|
| GA21260-100mg |
|
4289-02-5 |
Characteristic MSH-Tetrapeptide
|
0 |
C32H40N10O5 |
|
|
|
| GA21260-25mg |
|
4289-02-5 |
Characteristic MSH-Tetrapeptide
|
0 |
C32H40N10O5 |
|
|
|
| GA21259-1mg |
|
114679-42-4 |
|
0 |
C165H262N52O50S2 |
|
|
|
| GA21259-005mg |
|
114679-42-4 |
|
0 |
C165H262N52O50S2 |
|
|
|
| GA21258-1mg |
|
201608-15-3 |
Cell-permeable Caspase-3 Inhibitor I
|
0 |
C94H158N20O27 |
|
|
|
| GA21258-005mg |
|
201608-15-3 |
Cell-permeable Caspase-3 Inhibitor I
|
0 |
C94H158N20O27 |
|
|
|
| GA21257-1mg |
|
201608-12-0 |
Cell-permeable Caspase-1 Inhibitor I
|
0 |
C97H160N20O24 |
|
|
|
| GA21257-005mg |
|
201608-12-0 |
Cell-permeable Caspase-1 Inhibitor I
|
0 |
C97H160N20O24 |
|
|
|
| GA21256-1mg |
|
125667-96-1 |
|
0 |
C147H253N45O43 |
|
|
|
| GA21256-005mg |
|
125667-96-1 |
|
0 |
C147H253N45O43 |
|
|
|
| GA21255-5mg |
|
129696-23-7 |
Cecropin A (1-8)-Melittin (1-18) amide
|
0 |
C136H233N33O29 |
|
|
|
